Paul Toren

1.8k total citations
77 papers, 1.2k citations indexed

About

Paul Toren is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Paul Toren has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 19 papers in Oncology. Recurrent topics in Paul Toren's work include Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Paul Toren is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Paul Toren collaborates with scholars based in Canada, United States and Brazil. Paul Toren's co-authors include Amina Zoubeidi, Martin Gleave, Soojin Kim, Laurence Klotz, Yves Fradet, Vasundara Venkateswaran, Frédéric Pouliot, Antonio Finelli, Louis Lacombe and Keyue Ding and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Paul Toren

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Toren Canada 19 681 425 272 235 228 77 1.2k
Takehiko Segawa Japan 18 642 0.9× 600 1.4× 225 0.8× 144 0.6× 190 0.8× 61 1.3k
Nathalie Nicolaı̈ew France 19 726 1.1× 418 1.0× 220 0.8× 156 0.7× 158 0.7× 25 1.3k
Jie Jin China 24 849 1.2× 676 1.6× 310 1.1× 296 1.3× 375 1.6× 103 1.7k
Kiyoshi Fujinami Japan 19 442 0.6× 549 1.3× 208 0.8× 197 0.8× 245 1.1× 45 1.2k
Edwin Herrmann Germany 21 653 1.0× 674 1.6× 506 1.9× 297 1.3× 396 1.7× 47 1.5k
Denglong Wu China 24 312 0.5× 805 1.9× 497 1.8× 172 0.7× 152 0.7× 87 1.5k
Kiyoshi Koshida Japan 19 399 0.6× 502 1.2× 183 0.7× 219 0.9× 218 1.0× 80 1.2k
Mari Nakabayashi United States 22 914 1.3× 453 1.1× 455 1.7× 144 0.6× 292 1.3× 40 1.5k
Wm. Kevin Kelly United States 17 678 1.0× 900 2.1× 227 0.8× 100 0.4× 505 2.2× 34 1.7k
Ericka M. Ebot United States 15 598 0.9× 413 1.0× 401 1.5× 103 0.4× 310 1.4× 36 1.2k

Countries citing papers authored by Paul Toren

Since Specialization
Citations

This map shows the geographic impact of Paul Toren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Toren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Toren more than expected).

Fields of papers citing papers by Paul Toren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Toren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Toren. The network helps show where Paul Toren may publish in the future.

Co-authorship network of co-authors of Paul Toren

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Toren. A scholar is included among the top collaborators of Paul Toren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Toren. Paul Toren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lopes, Roberto Iglesias, Valeria Campos, José Maurício Mota, et al.. (2025). Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment—A Systematic Review of Current Evidence. European Urology Open Science. 79. 45–59.
2.
3.
Cordeiro, Maurício, Leonardo Cardili, José Maurício Mota, et al.. (2024). Artificial intelligence for predicting response to neoadjuvant chemotherapy for bladder cancer. Canadian Urological Association Journal. 18(9). E276–E284. 5 indexed citations
4.
Savard, Josée, Jean‐François Pelletier, Pierre Julien, et al.. (2023). Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial. Cancer Medicine. 12(19). 20163–20176. 8 indexed citations
5.
Tremblay, Samuel, Frédéric Pouliot, Juanita Crook, et al.. (2021). Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer. The Journal of Urology. 206(5). 1166–1176. 3 indexed citations
6.
Goulet, Cassandra Ringuette, Thierry Dujardin, Yves Fradet, et al.. (2021). 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy. Canadian Urological Association Journal. 15(10). 301–307. 6 indexed citations
7.
Wagner, Daniel‐Christoph, Axel Haferkamp, Philippe Joubert, et al.. (2021). Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors. Urologic Oncology Seminars and Original Investigations. 39(5). 303.e1–303.e8. 3 indexed citations
8.
9.
Joncas, France‐Hélène, Fabrice Lucien, Mélanie Rouleau, et al.. (2019). Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients. The Prostate. 79(15). 1767–1776. 60 indexed citations
10.
Nguilé-Makao, Molière, Isabelle Bairati, François Meyer, et al.. (2019). Charlson Comorbidity Index as a Predictor of Cancer Mortality Beyond 10 Years after Radical Prostatectomy. 4(1). 2 indexed citations
11.
Nguilé-Makao, Molière, et al.. (2019). Neutrophil-to-lymphocyte Ratio as a Predictive Marker of Response to Abiraterone Acetate: A Retrospective Analysis of the COU302 Study. European Urology Oncology. 3(3). 298–305. 19 indexed citations
12.
Toren, Paul, Keyue Ding, France‐Hélène Joncas, et al.. (2018). Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial. Clinical Cancer Research. 24(21). 5305–5312. 15 indexed citations
13.
Julien, Anne‐Sophie, et al.. (2018). Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(8). 363.e7–363.e11. 18 indexed citations
14.
Toren, Paul, et al.. (2018). Sex steroids in the tumor microenvironment and prostate cancer progression. Endocrine Related Cancer. 25(3). R179–R196. 27 indexed citations
15.
Toren, Paul, Soojin Kim, Fraser Johnson, & Amina Zoubeidi. (2016). Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer. PLoS ONE. 11(4). e0152861–e0152861. 27 indexed citations
16.
Toren, Paul, Soojin Kim, Steven Pham, et al.. (2014). Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 14(1). 59–69. 79 indexed citations
17.
Toren, Paul & Amina Zoubeidi. (2014). Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review). International Journal of Oncology. 45(5). 1793–1801. 134 indexed citations
18.
Toren, Paul & Vasundara Venkateswaran. (2013). Periprostatic Adipose Tissue and Prostate Cancer Progression: New Insights into the Tumor Microenvironment. Clinical Genitourinary Cancer. 12(1). 21–26. 35 indexed citations
19.
Toren, Paul, et al.. (2009). Comparison of epidural and intravenous patient controlled analgesia in patients undergoing radical cystectomy.. PubMed. 16(4). 4716–20. 17 indexed citations
20.
Heek, Margaret van, David Schmitt, Paul Toren, Martha K. Cathcart, & Paul E. DiCorleto. (1998). Cholesteryl Hydroperoxyoctadecadienoate from Oxidized Low Density Lipoprotein Inactivates Platelet-derived Growth Factor. Journal of Biological Chemistry. 273(31). 19405–19410. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takehiko Segawa Breakdown of academic impact, for papers by Nathalie Nicolaı̈ew Breakdown of academic impact, for papers by Jie Jin Breakdown of academic impact, for papers by Kiyoshi Fujinami Breakdown of academic impact, for papers by Edwin Herrmann Breakdown of academic impact, for papers by Denglong Wu Breakdown of academic impact, for papers by Kiyoshi Koshida Breakdown of academic impact, for papers by Mari Nakabayashi Breakdown of academic impact, for papers by Wm. Kevin Kelly Breakdown of academic impact, for papers by Ericka M. Ebot
Rankless by CCL
2026